Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celera Pharma Private Limited is an Indian pharmaceutical company headquartered in Hyderabad, specializing in the development, manufacturing, and marketing of high-quality pharmaceutical formulations and generic medicines. Established in 2011, the company focuses on critical therapeutic areas including nephrology, cardiology, neurology, urology, and diabetology. Its commercial portfolio features established brands such as Celglip, Tacrorite, and Mycorite, which address chronic conditions and post-transplant care. Celera Pharma also operates as a custom research organization (CRO) and maintains strategic international partnerships, such as with EVER Neuro Pharma, to enhance its specialized product offerings. The company is dedicated to providing affordable and effective healthcare solutions through a robust distribution network across India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celera Pharma.